XENE - Xenon Pharmaceuticals Inc.
43.05
-0.740 -1.719%
Share volume: 1,127,122
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$43.79
-0.74
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-12-2025 | 08-11-2025 | 11-03-2025 | 02-26-2026 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | 12.130 M | 1.151 M | 65.000 K | 2.360 M | 113.537 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 1.151 M | 65.000 K | 2.360 M | 113.537 M | |
| Cash flow | -89.380 M | 0.000 | 0.000 | 56.248 M | -25.991 M | 18.092 M | -30.861 M | 94.753 M | |
| Net income | -47.931 M | -57.924 M | -62.790 M | -65.685 M | -65.047 M | -84.706 M | -90.896 M | -105.261 M | |
| Depreciation | 599.000 K | 659.000 K | 669.000 K | 633.000 K | 659.000 K | 632.000 K | 641.000 K | 611.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -46.202 M | 110.719 M | 1.980 M | 98.503 M | 34.510 M | 82.260 M | 38.531 M | 62.697 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 188.000 K | 1.514 M | 590.000 K | 783.000 K | 43.000 K | 157.000 K | 281.000 K | 318.000 K | |
| Cash Change | -89.747 M | 77.838 M | -49.113 M | 55.091 M | -26.055 M | 18.724 M | -30.867 M | 94.649 M |